Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
Krishan K PandeyInstitute for Molecular Virology, Saint Louis University Health Sciences Center, St Louis, MO, USAAbstract: Human immunodeficiency virus type 1 (HIV-1) integrase inhibitors belong to a novel class of antiretroviral drugs with high potency and better tolerability. Elvitegravir (EVG)...
Enregistré dans:
Auteur principal: | |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c93ccd2a03dd4d348281ebbadd87a718 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|